Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 91

Kindbody consults GV in $62m series C

GV participated in a series C round for the fertility and gynaecology services provider at a $612m valuation, doubling its overall funding.

Jun 28, 2021

Daily Deal Round Up: June 25, 2021

Waste management software provider Recycle Track Systems bagged $35m in a Citi-led series C round while muscular dystrophy drug developer Vita Therapeutics completed a $32m series A.

Jun 25, 2021

Abbisko aims for Hong Kong IPO

The AstraZeneca, Sinopharm and Eli Lilly-backed oncology drug developer has revealed its intention to go public in a Hong Kong IPO that could reportedly fetch $250m.

Jun 25, 2021

Monte Rosa blows through $222m IPO

GV notched up an exit as cancer therapy developer Monte Rosa Therapeutics priced an upsized initial public offering at the top of its range.

Jun 25, 2021

Memed takes care with new funding

DNA Capital has returned to lead a $59.5m round for the Qualcomm Ventures-backed digital prescription startup.

Jun 25, 2021

Daily Deal Round Up: June 24, 2021

BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.

Jun 24, 2021

Novo leads Quanta to $245m series D

Novo and Orlando Health helped the haemodialysis technology provider increase its overall funding to $350m since it was spun off by IMI.

Jun 24, 2021

Boston Scientific bonds with Farapulse for $295m

Long-term investor Boston Scientific is paying $295m upfront for the 73% of the ablation technology developer it does not own.

Jun 24, 2021

Glycomine glides to $68m series B round

Sanofi Ventures co-led replacement therapy developer Glycomine's latest round, which included Novo, Asahi Kasei Pharma Ventures and Chiesi Ventures.

Jun 24, 2021

ImmuneID nets $50m in series A

Alexandria Venture Investments backed precision immunology therapeutics developer ImmuneID in the round, which was led by venture capital firm Alta Partners.

Jun 24, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here